Replies to post #42089 on OncoSec Medical Inc (ONCSQ)

[dr_lowenstein]

who says that 10 billion of valuation is attributable to this one drug? to compare these two total nonsense. Please tell us the full scope of the Epacadostat clinical program, (the patient numbers well exceed several thousand), then compare that to the cheap short cut program that ONCS is pursuing

[Titan V]

Yes, the other half of INCY valuation accounts for its revenues and cash but Epcadostat valuation ($10B+) is based on data not better than ONCS’ and expectations, so far, as pointed out by Adam Feuerstein.